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Abstract: In the absence of chemoprophylaxis, HIV-1 transmission occurs in 13-42% of infants born to HIV-1 positive 
mothers. All exposed infants acquire maternal HIV-1 antibodies that persist for up to 15 months, thereby hampering diag-
nosis. In resource limited settings, clinical symptoms are the indices of established infection against validated laboratory-
based markers. Here we enrolled 1200 children hospitalized for diarrheal and other illnesses. 20-25% of those tested, aged 
15 months or younger, were found to be HIV-1-seropositive. Where sufficient plasma was available, HIV-1 RNA detec-
tion was performed using a subtype-insensitive assay, with 71.1% of seropositive infants presenting with diarrhea show-
ing positive. From sub-typing analysis, we identified that viruses of the C’ sub-cluster were predominated amongst in-
fants. Although this study may overestimate the HIV-1 frequency through testing symptomatic infants, diarrhea can be 
seen as a useful marker indicating HIV-1 infection in infants less than 15 months old. 
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INTRODUCTION 
  The burden of pediatric HIV-1 infection remains high in 
Africa, where over 90% of the 3 million HIV-1-infected 
children reside [1]. The vast majority acquire the infection 
from seropositive mothers either during pregnancy, during 
labor and delivery or post-partum through breastfeeding [2-
5]. Various initiatives are underway in the region to imple-
ment short-course antiretroviral regimens for the prevention 
of mother-to-child-transmission [6, 7]. In the absence of any 
intervention, transmission occurs in 13-42% of infants [8]. 
Antibody-based tests for diagnosing perinatally acquired 
HIV-1 infection have limited value, since maternally ac-
quired antibodies are present in both infected and uninfected 
infants [9, 10]. Where antigen or viral RNA-based studies 
are lacking, children are considered infected only, if HIV-1 
antibody persists beyond 15 months, or if death occurs from 
AIDS or an HIV-1-related cause [11]. 
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  Laboratory-based diagnosis of HIV-1 infection is not 
always feasible, and in such circumstances presumptive   
diagnosis relying on clinical symptoms has been used as an 
alternative approach [12]. Studies that critically evaluate the 
association between clinical manifestations presumed to be 
HIV-1-related and laboratory confirmed diagnosis of HIV-1 
infection would help in developing HIV-1 testing algorithms 
or clinical guidelines to identify symptomatic HIV-1 infec-
tion. Indeed, this has long been recognized as a priority need 
for developing countries, where resources for confirmatory 
testing are scarce [13]. 
  Here we report on the extent of established HIV-1 infection 
in a group of HIV-1-seropositive Ethiopian infants, 15 months 
of age or less. The majority of the infants presented with diar-
rhea were evaluated for the presence of HIV-1 RNA, as an in-
dicative of established infection. This study also provides an 
indirect estimate of the predictive value of diarrhea as a marker 
that flags the presence of HIV-1 infection in Ethiopian infants. 
We also investigated the virus genotype (subcluster C or C’) in 
this population of infants living in a setting where HIV-1 sub-
type C predominates in adults [14-17]. It is the first report on the 
genotypes infecting children in Ethiopia by utilising a newly 20    The Open AIDS Journal, 2009, Volume 3  Ayele et al. 
developed molecular tool to discriminate between HIV-1 sub-
clusters C and C’, co-circulating in the country. 
MATERIALS & METHODS 
Selection of Subjects 
  The samples for this study were drawn from a project origi-
nally designed to investigate the etiological agents of childhood 
diarrhea in Addis Ababa, Ethiopia. This was a cross-sectional 
study which involved children under 5 years of age who had 
acute or chronic diarrhea seen at 3 hospitals in Addis Ababa 
(Tikur Anbessa Referral and Teaching Hospital, Yekatit 12 
Hospital and Armed Forces General Hospital), during April 
2000 - September 2001. Children presenting to the hospitals 
with complaints other than diarrhea were included as non-
diarrheal controls. 
Ethical Approval 
  The study was approved by the Research and Ethical Clear-
ance Committee of the Ethiopian Health and Nutrition Research 
Institute, and the National Ethical Clearance Committee at the 
Ethiopian Science and Technology Commission. 
Serology 
  Within the scope of the original study, plasma from the   
children was screened for antibodies to HIV-1/HIV-1-2   
(Vironostika HIV-1, Uni-Form II plus O, bioMérieux, Boxtel, 
The Netherlands), and positive results were confirmed by using 
Western Blot (HIV-1 Blot 2.2, Genelabs Diagnostics,   
Singapore). 
HIV-1 RNA Testing 
  A subset of HIV-1-seropositive children, aged 15 months 
and under with diarrhea, were selected for HIV-1 RNA screen-
ing using the LTR-based NASBA assay (Primagen, The Neth-
erlands), performed according to the manufacturer’s instruc-
tions, and previously shown to have a demonstrated capacity to 
detect a range of HIV-1 subtypes efficiently [18]. In addition 
plasma from seropositive children above the age of 24 months 
was screened for HIV-1 RNA as a positive control for the assay 
(N=5), as well as plasma from age-matched (15 months or 
younger) seronegative infants, serving as negative controls 
(N=5). 
Envelope V3-loop Genotyping 
  HIV-1 RNA available was utilized in the env-based NASBA-
molecular beacon assay for the genotype determination de-
scribed elsewhere [19]. 
Statistical Analyses 
  Statistical analyses were performed, using the STATA com-
puter package (Stata Statistical Software, Stata Corporation, 
College Station, Texas, USA). Analyses were performed using 
the Wilcoxon rank-sum test. 
RESULTS 
Serology 
  Eight hundred and nine children presented with diarrhea 
and 395 non-diarrheal controls were included in this study. A 
total of 540 children with diarrhea and 269 non-diarrheal 
children were tested for the presence of HIV-1 antibodies. A 
total of 116 (14.3%) children were HIV-1-seropositive, with a 
median age of 24 months (IQR 12-42), 103 and 13 amongst the 
diarrheal and non- diarrheal groups, respectively. The difference 
in HIV-1-seropositivity between the diarrheal and non-diarrheal 
group (19.1% versus 4.8%) was highly significant (p<0.001). 
  The age breakdown and percent HIV-1-seropositive per 
group are presented (Fig. 1). In the diarrheal group, HIV-1-
seropositivity was highest (24.5%) in the youngest age category 
of 0-7 months and there was an overall declining trend in sero-
positivity with increase in age (p<0.001). In the non-diarrheal 
controls, the median age was 42 months (IQR 26-51). In the 
non-diarrheal seropositivity was highest (9.7%) among the   
children in the age bracket 32-39 months with no significant 
trend of declining prevalence with age (p=0.54), possibly due to 
the low numbers of seropositive children in this group. 
 
Fig. (1). HIV-1 antibody prevalence amongst the study participants in 
both the diarrheal (n=540) and non-diarrheal groups (n=269). All   
children were 5 years old or under and were divided in six subgroups 
according to their age. The arrow indicates the marked initial decline of 
antibody positivity due to the acquisition of maternal anti-HIV   
antibodies. 
Detection of HIV-1 RNA, Using the LTR-based NASBA 
Assay 
  Amongst the 60 infants aged 15 months or less for the diar-
rhea group that were HIV-1-seropositive, plasma for HIV-1 
RNA testing was available from only 38. Out of these, 27 
(71.1%) tested positive for HIV-1 RNA. 11 out of 18 (61.1%) 
were in the age group of 0-7 months and 16 out of 20 infants 
(80%) were in the age group of 8-15 months (Fig. 2). In the age-
matched non-diarrheal control group, only 1 HIV-1-seropositive 
child was identified; this infant tested positive for HIV-1 RNA 
as well. HIV-1 RNA was detected in the plasma of all children 
older than 24 months that were seropositive but in none of the 
seronegative children under 15 months of age (data not shown). 
Envelope V3-loop Genotyping 
  The genotype of the V3 domain of the Env protein was 
determined utilizing a newly developed molecular beacon 
based NASBA assay, and the 27 diarrheal infants positive 
for both HIV-1 antibody and RNA were genotyped. Twenty-
two could be unambiguously genotyped as subcluster C or 
C’. Genotype could not be determined for 5 children by the HIV-1 RNA in Seropositive Ethiopian Infants with Diarrhea  The Open AIDS Journal, 2009, Volume 3    21 
beacon assay, despite the presence of substantial viral load in 
plasma of the infants. Two of the five samples could be 
genotyped as cluster C’ by sequencing the C2V3 region of 
the envelope region. Three of the infants could not be geno-
typed using either the beacon assay or sequencing. In total 
nine (37.5%) infants that were infected with a subtype 
C/subcluster C virus and 15 (62.5%) with a subtype C/sub-
cluster C’ virus corroborated adult epidemiological data 
from both the capital Addis Ababa and the rest of the coun-
try [20]. This indicates that transmission rates for the geno-
types C and C’ are similar for horizontal and mother to child 
transmission of HIV-1. 
 
Fig (2). Frequency of detectable HIV-1 RNA in seropositive chil-
dren with diarrhea needed nosocomial care of 15 months old or 
younger. The study subjects were divided in two subgroups accord-
ing to their age. 
Characteristics of HIV-1 RNA-Positive Infants with   
Diarrhea 
  Twenty-seven of 38 HIV-1 seropositive infants (71.1%) 
of age 15 months or less were positive for HIV-1 RNA and 
we summarize the results in Table 1. Overall median age was 
8 months [IQR 5-12]. Fifteen of the infants were male and 
12 were female, with no significant difference in median age 
by gender: 9 months [IQR 5-12] versus 8 months [IQR 4.5-
9] for males and females, respectively (p=0.54). The overall 
median viral load was 5.0 log10 copies/ml [IQR 4.2-5.6]. The 
median viral load was slightly higher for females but the 
difference was not significant (4.6 log10 copies/ml and 5.2 
log10 copies/ml for males and females respectively, p=0.150). 
The median age of C and C’-infected infants was similar (8 
months for both subclusters, p=0.509). 
  Viral load was significantly higher in the younger age cate-
gory (0-7 months) as compared to the 8-15 months group (5.6 
log10 copies/ml [IQR 5.1-6.5] versus 4.4 log10 copies/ml [IQR 
4.0-5.0], respectively, p=0.020). When genotype was addition-
ally considered in the analysis, a similar significantly higher 
difference in viral load was observed in the younger infants (5.2 
log10 copies/ml and 4.3 log10 copies/ml for subcluster C, 
p=0.028, but not for subcluster C’: 5.6 log10 copies/ml and 4.95 
log10 copies/ml, p=0.066). However, within age-matched group-
ings, there was no difference in viral load between the sub-
clusters (5.2 log10 copies/ml and 5.6 log10 copies/ml for C and 
C’ respectively, in the 0-7 months age group, p=0.142). 
  In the 8-15 months age category, viral load was 4.3 log10 
copies/ml and 5.0 log10 copies/ml for C and C’ respec-
tively,(p=0.391). No significant difference in median viral 
load was found when comparing different age categories 
within genders (5.4 log10 copies/ml and 4.3 log10 copies/ml 
for males in the age categories 0-7 months and 8-15 months 
respectively, p=0.126). For females viral load was 5.6 log10 
copies/ml and 5.0 log10 copies/ml in the two age groups, 
p=0.123). Similarly no difference was observed in viral load 
between the genders compared within the same age catego-
ries (p=0.465 for the 0-7 months group, and p=0.244 for the 
age group 8-15 months). Again it should be noted that small 
sample sizes of the groups may obscure the identification of 
statistical differences between parameters tested. 
DISCUSSION 
  HIV-1 disease has emerged as the most important cause 
of morbidity and mortality in children under 5 years of age 
in many African countries
 and reversed the improvements in 
under-five mortality rates achieved in preceding decades 
[21]. The diagnosis of pediatric HIV-1 infection initially 
relied on the detection of viral DNA in peripheral blood 
mononuclear cells using the polymerase chain reaction or 
virus co-culture techniques [22, 23]. Assays to detect HIV-1 
RNA were subsequently developed that helped to character-
ize HIV-1 infection in children [24, 25], and also served as 
valuable predictors of disease outcome [26]. 
  Diarrhea as a clinical manifestation of underlying HIV-1 
infection in children is well recognized [27-29]. In Africa, diar-
rhea has been recognized as an important medical complication 
of HIV-1 infection [30, 31]. Indeed a high proportion (71.1%) 
of the HIV-1-seropositive infants with diarrhea in our study had 
detectable HIV-1 RNA in their plasma, indicating established 
HIV-1 infection. Our results suggest that diarrhea is a major 
clinical manifestation in HIV-1-infected children in Ethiopia, an 
observation which concurs with previously reported findings 
[32-34], although none of these studies utilized HIV-1 RNA 
detection methods to diagnose infection. Earlier studies did not 
focus particularly on young infants under 15 months of age, 
where HIV-1 antibody positivity is not conclusive evidence of 
an established infection. Taking all children in the study into 
consideration, there were nearly three times as many seroposi-
tive children in the group with diarrhea than in the non-diarrheal 
group (19.1% versus 4.8%). This finding provides an indirect 
clue that the presence of diarrhea is a major warning symptom 
to signal established HIV-1 infection in Ethiopian infants. Thus, 
where laboratory diagnosis of HIV-1 is not feasible or is limited 
to antibody detection assays alone, the presence of diarrhea in 
infants below the age of 15 months may serve as a good proxy 
indicator of established pediatric HIV-1 infection in Ethiopia. 
  The source of HIV-1 infection in our series of infants cannot 
be stated with certainty, although from the age group involved, 
it can be reasonably assumed that a significant proportion of the 
infections would have been transmitted from HIV-1-
seropositive mothers. Vertical or mother-to-child-transmission 
has previously been documented to be responsible for 80-90% 
of HIV-1 infections seen in young children [35], with levels of 
maternal HIV-1 RNA as an important risk factor [36, 37]. HIV-
1 seroprevalence estimates in pregnant Ethiopian women at-22    The Open AIDS Journal, 2009, Volume 3  Ayele et al. 
tending antenatal clinics in the capital city Addis Ababa were 
15.6%
 in 2001 [38]. We would expect a similar level of sero-
positivity in our study which was conducted within approxi-
mately the same time frame. However, blood samples were not 
available from any of the mothers in our study and therefore, 
their HIV-1 serostatus could not be investigated. 
  Our study was cross-sectional, limiting us from making 
broader inferences about the trend of HIV-1-antibody seroposi-
tivity over time for a group of 116 seropositive children aged 0-
5 years. However, the fact that HIV-1 seroprevalence was high-
est in the youngest infants and also the declining trend with in-
creasing age, suggests that a substantial fraction of the early 
seropositivity represents maternally acquired antibodies and not 
true infection. Alternatively, the fewer numbers of seropositive 
children in the older age groups could also be a reflection of 
mortality, since many infected children die at an early age, leav-
ing fewer children in the higher age groups. Mostly infected 
children develop AIDS and die within the first two years and 
few survive past the age of 5 years [38]. In our study, of those 
children infected but surviving beyond the first year of life there 
was a progressive decline in antibody positivity past the age of 2 
years, which was followed again by a slight increase in the 32-
39 months age category. 
  Envelope genotype analysis of the HIV-1 RNA-positive 
samples using molecular beacons was performed. Most samples 
were observed to have subcluster C’ sequences which currently 
predominate in Ethiopia. The proportion of C and C’ isolates 
was 37.5% and 62.5% respectively, consistent with sequence 
data from studies among adult Ethiopians, which show a trend 
of increasing prevalence for subcluster C’ over time. Infants 
infected with subcluster C’ had higher mean viral loads as com-
pared to subcluster C-infected ones, although this difference is 
not statistically significant. There was a significant difference in 
viral load only when comparing the different age categories, 
being higher in the younger age group. The median ages of C 
and C’-infected infants were similar, so the higher viral load 
observed in the C’-infected group was not a function of younger 
age in this group of children. However, from the studies in HIV-
1-seropositive adults being followed longitudinally in Ethiopia, 
there is an indication of significantly higher viral loads in C’-
infected individuals as compared to subcluster C-infected per-
sons who are at a similar stage of infection (manuscript in 
preparation). The lack of similar finding in the present study 
may reflect the small sample size. 
  In summary, the findings reported in this study support the 
initial hypothesis that diagnosis of diarrhea can be a major clini-
cal symptom of underlying HIV-1 infection in young children. 
Our study used HIV-1 diagnosis based on the detection of HIV-
1 RNA in the infants’ samples, rather than antibody-based as-
says that are of limited value for children under the age of 15 
months. On the other hand, the choice of subjects in our study 
(hospital-based with diarrhea) may introduce a significant bias 
due to the selection of an already symptomatic group, risking an 
overestimation of the extent of established HIV-1 infection in 
seropositive children in general. 
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Table 1.  Characteristics of HIV-1 RNA-Positive Infants 15 Months and Under with Diarrhoea 
 
 
 
Median Age by Gender (months)  (N=27) 
 
Median Viral Load by Gender (log10 copies/ml) (N=27) 
Male (N=15) 
 
9 [5-12] 
 
4.6 [3.7-5.6] 
Female (N=12) 
 
8 [4.5-9] 
 
5.2 [4.6-6.0] 
p-value 
 
0.540 
 
0.150 
 
 
Median Age by Genotype (months)  (N=24) 
 
Median Viral Load by Genotype (log10 copies/ml) (N=24) 
C (N=9) 
 
8 [4-12] 
 
4.6 [4.3-5.1] 
C’ (N=15) 
 
8 [6-10] 
 
5.2 [4.2-5.8] 
 
 
0.509 
 
0.270 
 
Median Viral Load by Age Category (log10 copies/ml) (N=27) 
 
 
0-7 months  
 
5.6 [5.1-6.5] (N=11) 
 
8-15 months  
 
4.4 [4.0-5.0] (N=16) 
 
 
 
0.020 
 
Median Viral Load by Age Category & Genotype (log copies10/ml)  
 
0-7 months 
 
8-15 months 
 
Median Viral Load by Gender & Age Category (log copies10/ml)  
 
Male 
 
Female 
 
C 
 
5.2[4.9-5.6] (N=4) 
 
4.3[4.3-4.5] (N=5) 
 
0-7 months 
 
5.4[4.6-5.9] (N=6) 
 
5.6[5.3-6.5] (N=5) 
 
C’ 
 
5.6 [5.6-6.5] (N=5) 
 
5.0 [4.1-5.6] (N=10) 
 
8-15 months 
 
4.3 [3.7-4.9] (N=9) 
 
5.0 [4.1-5.6] (N=7) 
 
 
 
0.142 
 
0.391 
 
 
 
0.126 
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